Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
Filter results of approved projects table below
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Ultraprocessed Food consumption and Dietary Antioxidant index and incident of Lung Cancer among adult population of US: Evidence from Prostate, Lung, Colorectal and Ovarian Cancers Trial | Tefera Mekonnen | The University of Adelaide | PLCO | May 23, 2022 | PLCO-982 |
| Associations of age at menopause with health outcomes and mortality among females who are moderate and heavy smokers | Shuguang Leng | Regents of the University of New Mexico for its Public Operation Known as the Health Sciences Center | PLCO | May 11, 2022 | PLCO-981 |
| An evaluation of SNP frequency, aspirin resistance, and adenoma/colorectal cancer risk in the PLCO study | Holli Loomans-Kropp | The Ohio State University | PLCO | May 9, 2022 | PLCO-978 |
| Privacy-preserving generation of synthetic patient data | Marcel Klamárik | Siemens Healthcare s.r.o. | PLCO | May 9, 2022 | PLCO-977 |
| A Hybrid Deep Learning and Machine Learning Technique to Predict Ovarian Cancer | Ahmad Ahmad | International Islamic University Chittagong | PLCO | May 9, 2022 | PLCO-976 |
| Data Mining Framework for Predicting Ovarian Cancer | Roopashri Shetty | Manipal Institute of Technology | PLCO | May 9, 2022 | PLCO-975 |
| BMI, its dietary determinants and lung cancer risk | Yumie Takata | Oregon State University | PLCO | Apr 25, 2022 | PLCO-973 |
| Joint modeling of longitudinal data and competing risks survival data with cause and time dependent masking | Vikas Barnwal | Banaras Hindu University | PLCO | Apr 25, 2022 | PLCO-972 |
| Interpretable AI prediction of prostate tumor staging | Björn Ommer | Ludwig Maximilian University of Munich (Machine Vision & Learning Group) | PLCO | Apr 25, 2022 | PLCOI-970 |
| Annotation-Ecient Medical Image Analysis | Jianming Liang | Arizona State University | PLCO | Apr 25, 2022 | PLCOI-880 |
| Deep Active Survival Analysis approach on Prostate Cancer treatment | Satyo Iswara | University of Illinois At Urbana-Champaign | PLCO | Apr 25, 2022 | PLCO-971 |
| Cancer Types Comparison and Analysis of them (statistical) | Nikos Letsios | Mediterranean College (Collaboration with University of Derby) | PLCO | Apr 25, 2022 | PLCO-968 |
| Evaluating a multi-biomarker panel for the early detection of ovarian cancer | Maxwell Akonde | University of South Carolina | PLCO | Apr 8, 2022 | PLCO-966 |
| Developing a breast cancer risk model for methodologic research on improving external validity of risk models | Hormuzd Katki | NCI | PLCO | Apr 8, 2022 | PLCO-964 |
| Metabolomic Profiles of Insulinemic Dietary Patterns and Colorectal Cancer Risk: A Consortium of Metabolomics Studies (COMETS) Analysis | Fred Tabung | The Ohio State University | PLCO | Apr 5, 2022 | PLCO-959 |
| Developing an all-cancer risk model for methodologic research on sampling designs for epidemiologic studies | Hormuzd Katki | NCI | PLCO | Apr 5, 2022 | PLCO-961 |
| GWAS of Metabolites | Erikka Loftfield | Erikka Loftfield Cronin | PLCO | Apr 4, 2022 | PLCO-960 |
| NCI Bladder GWAS | Stella Koutros | National Cancer Institute | PLCO | Mar 30, 2022 | PLCO-957 |
| Association between Benign Prostate Hyperplasia and Prostatitis as risk predictors of Prostate Cancer | Omar Catano | The University of Texas Health Science Center at San Antonio | PLCO | Mar 30, 2022 | PLCO-956 |
| Large Scale X-Ray and CT Representation Learning from Multi-Source | Chuang Niu | Rensselaer Polytechnic Institute | PLCO | Mar 30, 2022 | PLCOI-955 |